Literature DB >> 25041104

Cost effectiveness after a pancreaticoduodenectomy: bolstering the volume argument.

Jeffrey M Sutton1, Gregory C Wilson, Ian M Paquette, Koffi Wima, Dennis J Hanseman, R Cutler Quillin, Jeffrey J Sussman, Michael J Edwards, Syed A Ahmad, Shimul A Shah, Daniel E Abbott.   

Abstract

BACKGROUND: The cost implication of variability in pancreatic surgery is not well described. It was hypothesized that for a pancreaticoduodenectomy (PD), lower volume centres demonstrate worse peri-operative outcomes at higher costs.
METHODS: From 2009-2011, 9883 patients undergoing a PD were identified from the University HealthSystems Consortium (UHC) database and stratified into quintiles by annual hospital case volume. A decision analytic model was constructed to assess cost effectiveness. Total direct cost data were based on Medicare cost/charge ratios and included readmission costs when applicable.
RESULTS: The lowest volume centres demonstrated a higher peri-operative mortality rate (3.5% versus 1.3%, P < 0.001) compared with the highest volume centres. When both index and readmission costs were considered, the per-patient total direct cost at the lowest volume centres was $23,005, or 10.9% (i.e. $2263 per case) more than at the highest volume centres. One-way sensitivity analyses adjusting for peri-operative mortality (1.3% at all centres) did not materially change the cost effectiveness analysis. Differences in cost were largely recognized in the index admission; readmission costs were similar across quintiles.
CONCLUSIONS: For PD, low volume centres have higher peri-operative mortality rates and 10.9% higher cost per patient. Performance of PD at higher volume centres can lead to both better outcomes and substantial cost savings.
© 2014 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2014        PMID: 25041104      PMCID: PMC4253327          DOI: 10.1111/hpb.12309

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  15 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Delivering affordable cancer care in high-income countries.

Authors:  Richard Sullivan; Jeffrey Peppercorn; Karol Sikora; John Zalcberg; Neal J Meropol; Eitan Amir; David Khayat; Peter Boyle; Philippe Autier; Ian F Tannock; Tito Fojo; Jim Siderov; Steve Williamson; Silvia Camporesi; J Gordon McVie; Arnie D Purushotham; Peter Naredi; Alexander Eggermont; Murray F Brennan; Michael L Steinberg; Mark De Ridder; Susan A McCloskey; Dirk Verellen; Terence Roberts; Guy Storme; Rodney J Hicks; Peter J Ell; Bradford R Hirsch; David P Carbone; Kevin A Schulman; Paul Catchpole; David Taylor; Jan Geissler; Nancy G Brinker; David Meltzer; David Kerr; Matti Aapro
Journal:  Lancet Oncol       Date:  2011-09       Impact factor: 41.316

Review 3.  Outcome--more than just operative mortality.

Authors:  Murray F Brennan; Mark Radzyner; David M Rubin
Journal:  J Surg Oncol       Date:  2009-06-15       Impact factor: 3.454

4.  Quality pancreatic cancer care: it's still mostly about volume.

Authors:  Murray F Brennan
Journal:  J Natl Cancer Inst       Date:  2009-06-09       Impact factor: 13.506

5.  Is Illinois heeding the call to regionalize pancreatic surgery?

Authors:  Amanda V Hayman; Matthew J Fisher; Thomas Kluz; Ryan P Merkow; Edward C Wang; David J Bentrem
Journal:  J Surg Oncol       Date:  2013-01-17       Impact factor: 3.454

6.  Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy.

Authors:  J D Birkmeyer; S R Finlayson; A N Tosteson; S M Sharp; A L Warshaw; E S Fisher
Journal:  Surgery       Date:  1999-03       Impact factor: 3.982

7.  National and surgical health care expenditures, 2005-2025.

Authors:  Eric Muñoz; William Muñoz; Leslie Wise
Journal:  Ann Surg       Date:  2010-02       Impact factor: 12.969

8.  Hospital volume and operative mortality in cancer surgery: a national study.

Authors:  Emily V A Finlayson; Philip P Goodney; John D Birkmeyer
Journal:  Arch Surg       Date:  2003-07

9.  Importance of hospital volume in the overall management of pancreatic cancer.

Authors:  J A Sosa; H M Bowman; T A Gordon; E B Bass; C J Yeo; K D Lillemoe; H A Pitt; J M Tielsch; J L Cameron
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Surgeon volume and operative mortality in the United States.

Authors:  John D Birkmeyer; Therese A Stukel; Andrea E Siewers; Philip P Goodney; David E Wennberg; F Lee Lucas
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

View more
  6 in total

1.  An Evaluation of Artificial Neural Networks in Predicting Pancreatic Cancer Survival.

Authors:  Steven Walczak; Vic Velanovich
Journal:  J Gastrointest Surg       Date:  2017-08-03       Impact factor: 3.452

2.  Overuse of surgery in patients with pancreatic cancer. A nationwide analysis in Italy.

Authors:  Gianpaolo Balzano; Giovanni Capretti; Giuditta Callea; Elena Cantù; Flavia Carle; Raffaele Pezzilli
Journal:  HPB (Oxford)       Date:  2016-02-05       Impact factor: 3.647

Review 3.  Quality Versus Costs Related to Gastrointestinal Surgery: Disentangling the Value Proposition.

Authors:  Rohan Shah; Adrian Diaz; Marzia Tripepi; Fabio Bagante; Diamantis I Tsilimigras; Nikolaos Machairas; Fragiska Sigala; Dimitrios Moris; Savio George Barreto; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2020-07-23       Impact factor: 3.452

4.  Cost-Effectiveness in Hepatic Lobectomy: the Effect of Case Volume on Mortality, Readmission, and Cost of Care.

Authors:  Jeffrey M Sutton; Richard S Hoehn; Audrey E Ertel; Gregory C Wilson; Dennis J Hanseman; Koffi Wima; Jeffrey J Sussman; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2015-10-01       Impact factor: 3.452

5.  Surgeon Variation in Intraoperative Supply Cost for Pancreaticoduodenectomy: Is Intraoperative Supply Cost Associated with Outcomes?

Authors:  David G Brauer; Kerri A Ohman; David P Jaques; Cheryl A Woolsey; Ningying Wu; Jingxia Liu; M B Majella Doyle; Ryan C Fields; William C Chapman; Steven M Strasberg; William G Hawkins
Journal:  J Am Coll Surg       Date:  2017-10-19       Impact factor: 6.113

6.  The burden of metastatic disease of the femur on the Medicare system.

Authors:  Kirollos Gendi; David Hennessy; John Heiner
Journal:  Springerplus       Date:  2016-11-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.